Related Experiment Video
Updated: Feb 13, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Dexmedetomidine improves the outcomes in paediatric cardiac surgery: a meta-analysis of randomized controlled trials
Yang Liu1, Weishuai Bian1, Ping Liu1
1Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Insights
Dexmedetomidine administration in pediatric cardiac surgery significantly reduces mechanical ventilation duration, intensive care unit, and hospital length of stay. It also lowers junctional ectopic tachycardia incidence, though postoperative deaths were unaffected.
Area of Science:
- Pediatric Cardiac Surgery
- Anesthesiology
- Critical Care Medicine
Background:
- Dexmedetomidine is known to decrease cardiac complications in adults undergoing cardiac surgery.
- Clinical trial results on dexmedetomidine's effects on pediatric cardiac surgery outcomes are conflicting.
Purpose of the Study:
- To evaluate the efficacy of dexmedetomidine in improving outcomes for pediatric patients undergoing cardiac surgery.
- To analyze its impact on mechanical ventilation duration, intensive care unit (ICU) and hospital length of stay (LOS), and the incidence of junctional ectopic tachycardia and postoperative deaths.
Main Methods:
- A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted.
- Searched EMBASE, PubMed, and Cochrane CENTRAL for studies comparing dexmedetomidine with placebo or other anesthetics in pediatric cardiac surgery patients.
- Primary outcome: duration of mechanical ventilation. Secondary outcomes: ICU LOS, hospital LOS, junctional ectopic tachycardia, and postoperative deaths.
Main Results:
- Nine trials involving 837 patients were analyzed.
- Dexmedetomidine significantly reduced mechanical ventilation duration (WMD -2.20 hours), ICU LOS (WMD -0.47 days), and hospital LOS (WMD -1.80 days).
- A significant reduction in postoperative junctional ectopic tachycardia was observed (RR 0.40), with no significant difference in postoperative deaths.
Conclusions:
- Perioperative dexmedetomidine may shorten mechanical ventilation and LOS in pediatric cardiac surgery patients.
- It may also decrease the incidence of junctional ectopic tachycardia.
- Further high-quality RCTs are recommended to confirm these benefits before widespread clinical application in pediatric congenital heart disease surgery.
Objectives:
Dexmedetomidine has been shown to decrease cardiac complications in adults undergoing cardiac surgery. Results from clinical trials of dexmedetomidine on outcomes following paediatric cardiac surgery are controversial.
Methods:
We searched EMBASE, PubMed and Cochrane CENTRAL databases for randomized controlled trials comparing the effect of dexmedetomidine versus placebo or other anaesthetic drugs in paediatric patients undergoing cardiac surgery. The primary outcome was the duration of mechanical ventilation. The secondary outcomes were intensive care unit stay, hospital length of stay (LOS), incidence of junctional ectopic tachycardia and postoperative deaths.
Results:
Nine trials with a total of 837 patients were selected. Compared with controls, dexmedetomidine significantly reduced the postoperative duration of mechanical ventilation [in hours; n = 837; weighted mean difference -2.20, 95% confidence interval (CI) -3.51 to -0.90; P = 0.001; I2 = 97%], intensive care unit LOS (in days; n = 737; weighted mean difference -0.47, 95% CI -0.90 to -0.03; P = 0.03; I2 = 97%) and hospital LOS (in days; n = 291; weighted mean difference -1.80, 95% CI -3.36 to -0.25; P = 0.02; I2 = 96%). Dexmedetomidine also significantly reduced the incidence of postoperative junctional ectopic tachycardia (21/292 vs 50/263; risk ratio 0.40, 95% CI 0.25-0.64; P = 0.0001; I2 = 0.0%), but there was no difference between groups in postoperative deaths (4/182 vs 6/153; odds ratio 0.54, 95% CI 0.15-1.93; P = 0.34; I2 = 0.0%).
Conclusions:
Perioperative administration of dexmedetomidine to paediatric patients undergoing cardiac surgery may shorten the duration of mechanical ventilation, LOS in the intensive care unit and in the hospital and reduce the incidence of junctional ectopic tachycardia. More high-quality randomized controlled trials are encouraged to verify the beneficial effect of dexmedetomidine before its clinical application in paediatric patients undergoing surgery for congenital heart disease.
Related Concept Videos
Statistical Software for Data Analysis and Clinical Trials
Trial and Error and Algorithm
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Predicting Reaction Outcomes
Directing Effect of Substituents: meta-Directing Groups

